These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 9222698

  • 1. The characteristics of hepatocellular carcinoma with a high level of serum lactic dehydrogenase: a case report.
    Fujiwara Y, Takenaka K, Kajiyama K, Maeda T, Gion T, Shirabe K, Shimada M, Sugimachi K.
    Hepatogastroenterology; 1997; 44(15):820-3. PubMed ID: 9222698
    [Abstract] [Full Text] [Related]

  • 2. Serum levels of des-gamma-carboxy prothrombin measured using the revised enzyme immunoassay kit with increased sensitivity in relation to clinicopathologic features of solitary hepatocellular carcinoma.
    Okuda H, Nakanishi T, Takatsu K, Saito A, Hayashi N, Takasaki K, Takenami K, Yamamoto M, Nakano M.
    Cancer; 2000 Feb 01; 88(3):544-9. PubMed ID: 10649245
    [Abstract] [Full Text] [Related]

  • 3. Usefulness of determining a protein induced by vitamin K absence in detection of hepatocellular carcinoma.
    Cui R, Wang B, Ding H, Shen H, Li Y, Chen X.
    Chin Med J (Engl); 2002 Jan 01; 115(1):42-5. PubMed ID: 11930656
    [Abstract] [Full Text] [Related]

  • 4. The effectiveness of serum alpha-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinoma.
    Peng YC, Chan CS, Chen GH.
    Hepatogastroenterology; 1999 Jan 01; 46(30):3208-11. PubMed ID: 10626187
    [Abstract] [Full Text] [Related]

  • 5. [Serum alpha-1-fetoprotein and serum lactic dehydrogenase isoenzymes in liver tumours (author's transl)].
    Polterauer P, Rauhs R, Puxkandl H.
    Wien Klin Wochenschr; 1981 Apr 03; 93(7):227-30. PubMed ID: 6167076
    [Abstract] [Full Text] [Related]

  • 6. AFP mRNA detected in bone marrow by real-time quantitative RT-PCR analysis predicts survival and recurrence after curative hepatectomy for hepatocellular carcinoma.
    Kamiyama T, Takahashi M, Nakagawa T, Nakanishi K, Kamachi H, Suzuki T, Shimamura T, Taniguchi M, Ozaki M, Matsushita M, Furukawa H, Todo S.
    Ann Surg; 2006 Sep 03; 244(3):451-63. PubMed ID: 16926571
    [Abstract] [Full Text] [Related]

  • 7. Fibrolamellar carcinoma of the liver with a mixture of ordinary hepatocellular carcinoma: a case report.
    Okano A, Hajiro K, Takakuwa H, Kobashi Y.
    Am J Gastroenterol; 1998 Jul 03; 93(7):1144-5. PubMed ID: 9672347
    [Abstract] [Full Text] [Related]

  • 8. An analysis of the UNOS liver transplant registry: high serum alpha-fetoprotein does not justify an increase in MELD points for suspected hepatocellular carcinoma.
    Kemmer N, Neff G, Kaiser T, Zacharias V, Thomas M, Tevar A, Satwah S, Shukla R, Buell J.
    Liver Transpl; 2006 Oct 03; 12(10):1519-22. PubMed ID: 17004260
    [Abstract] [Full Text] [Related]

  • 9. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
    Gadelhak NA, Gadelhak SA, El-Morsi DA, Abdelaziz MM, Abbas AT, El-Emshaty HM.
    Hepatogastroenterology; 2009 Oct 03; 56(94-95):1417-24. PubMed ID: 19950803
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Markers for hepatocellular carcinoma.
    Wu AH, Sell S.
    Immunol Ser; 1990 Oct 03; 53():403-22. PubMed ID: 1713067
    [Abstract] [Full Text] [Related]

  • 13. [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].
    Wu FS, Zheng SS, Wu LJ, Ding W, Ma ZM, Wang ZM, Teng LS, Zhao WH.
    Zhonghua Wai Ke Za Zhi; 2006 May 01; 44(9):603-8. PubMed ID: 16784653
    [Abstract] [Full Text] [Related]

  • 14. [A surgical case of solitary lymph node metastatic recurrence of hepatocellular carcinoma after hepatectomy].
    Tanaka K, Yamada K, Sasaki H, Kishi K, Noura S, Takachi K, Eguchi H, Miyashiro I, Ohue M, Ohigashi H, Yano M, Ishikawa O, Imaoka S.
    Gan To Kagaku Ryoho; 2006 Nov 01; 33(12):1938-40. PubMed ID: 17212152
    [Abstract] [Full Text] [Related]

  • 15. Serum ferritin in hepatocellular carcinoma.
    Zhou XD, Stahlhut MW, Hann HL, London WT.
    Hepatogastroenterology; 1988 Feb 01; 35(1):1-4. PubMed ID: 2452122
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Serum des-gamma-carboxyprothrombin level by a modified enzyme immunoassay method in hepatocellular carcinoma: clinical significance in small hepatocellular carcinoma.
    Soga K, Watanabe T, Aikawa K, Toshima M, Shibasaki K, Aoyagi Y.
    Hepatogastroenterology; 1998 Feb 01; 45(23):1737-41. PubMed ID: 9840138
    [Abstract] [Full Text] [Related]

  • 18. Markedly elevated alpha-fetoprotein levels without hepatocellular carcinoma.
    Cheema AW, Hirschtritt T, Van Thiel DH.
    Hepatogastroenterology; 2004 Feb 01; 51(60):1676-8. PubMed ID: 15532803
    [Abstract] [Full Text] [Related]

  • 19. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
    Soresi M, Magliarisi C, Campagna P, Leto G, Bonfissuto G, Riili A, Carroccio A, Sesti R, Tripi S, Montalto G.
    Anticancer Res; 2003 Feb 01; 23(2C):1747-53. PubMed ID: 12820452
    [Abstract] [Full Text] [Related]

  • 20. Increase in serum alpha-fetoprotein without recurrent disease after hepatectomy for hepatocellular carcinoma.
    Cristani A, Cioni G, De Santis M, Chianese L, Gozzetti G, Ventura E.
    Hepatogastroenterology; 1994 Apr 01; 41(2):137-9. PubMed ID: 7520014
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.